In this study, we analyze metastability, a feature of brain dynamics in subjects experiencing mild cognitive impairment Alzheimer's disease (MCI-AD) under eyes open (EO) and eyes closed (EC) conditions. Alzheimer's disease (AD) is a critically prolonged brain disorder that interrupts neural synchronization and desynchronization. Thus, studying metastability under EO and EC conditions would help in understanding the cortical dynamics and its impact in early-stage AD. Metastability is investigated using three methods namely frequency variance analysis, Kuramoto order parameter, and through meta-state activation patterns. Frequency variance estimated from 21 electroencephalogram (EEG) channels was clustered into three regions namely anterior, central, and posterior to study the regional metastability analysis. Global metastability was assessed from Kuramoto order parameter and meta-state activation patterns by collating the 21 EEG channels. Reduction in metastability was observed in central regions of MCI-AD subjects through the study of frequency variance analysis. There was a marked reduction in global metastability in the patient group under the resting EO condition. Reduction in meta-state activation properties such as temporal activation sequence complexity, modularity, and leap size in MCI-AD condition under the EO condition indicates an overall reduction in brain flexibility. Taken together, the study infers an underlying structural change in neuronal dynamics influencing the reduction of metastability under the MCI-AD condition. The study further revealed that this reduction in metastability is more pronounced in the EO condition.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/brain.2023.0041 | DOI Listing |
J Biomol Struct Dyn
December 2024
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Biruni University, Istanbul, Türkiye.
The increasing global prevalence of Alzheimer's disease necessitates the development of novel therapeutic approaches. Neurodegenerative diseases are associated with increased oxidative stress and levels of cholinesterase enzymes. Hence, the development of cholinesterase inhibitors and antioxidants may provide neuroprotective effects.
View Article and Find Full Text PDFZh Nevrol Psikhiatr Im S S Korsakova
December 2024
Federal Center of Brain Research and Neurotechnologies, Moscow, Russia.
Objective: Study of neuroimaging changes according to MRI morphometry and their comparison with the structure and severity of cognitive impairment (CI) in patients with Alzheimer's disease (AD) and primary open-angle glaucoma (POAG).
Material And Methods: The study involved 90 patients who were divided into two equal groups of 45 people and who early had diagnosis of AD (group 1; median age - 71 [66; 77] years) and POAG (group 2; median age - 68 [64; 77] years). 71] years).
Zh Nevrol Psikhiatr Im S S Korsakova
December 2024
Mental Health Research Center, Moscow, Russia.
Mental disorders are complex illnesses with multifactorial etiologies involving genetic and environmental components. This review focuses on cellular models derived from the olfactory epithelium as a promising tool to study the molecular mechanisms of some neuropsychiatric diseases. The authors consider cell lines allowing the identification of potential biomarkers and pathogenetic mechanisms of schizophrenia, bipolar disorder, and Alzheimer's disease.
View Article and Find Full Text PDFArch Pharm (Weinheim)
January 2025
Department of Pharmacognosy, University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India.
Alzheimer's disease (AD) is a prevalent neurological illness that affects over 80% of aged adults globally in cases of dementia. Although the exact pathophysiological causes of AD remain unclear, its pathogenesis is primarily driven by several distinct biochemical alterations: (i) the accumulation of toxic Aβ plaques, (ii) the hyperphosphorylation of tau proteins, (iii) oxidative stress resulting in cell death, and (iv) an imbalance between the two main neurotransmitters, glutamate and acetylcholine (ACh). Currently, there are very few medications available and no treatment.
View Article and Find Full Text PDFJpn J Radiol
December 2024
Department of Radiology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan.
Cerebral amyloid angiopathy (CAA) is an age-related small vessel disease pathologically characterized by the progressive accumulation of amyloid-beta (Aβ) peptide in cerebrovascular walls, affecting both cortical and leptomeningeal vessels. Amyloid deposition results in fragile vessels, which may lead to lobar intracerebral hemorrhage (ICH) and cognitive impairment. To evaluate the probability and severity of CAA, the imaging markers depicted on CT and MRI techniques are crucial, as brain pathological examination is highly invasive.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!